
Erayak Power Solution Group, Smart Powerr, Presidio Property Trust, Fusemachines, Sidus Space, XIAO-I, and Iovance Biotherapeutics are the seven Penny stocks to watch today, according to MarketBeat’s stock screener tool. “Penny stocks” are low-priced shares of very small or microcap companies—often trading for less than $5 per share and frequently quoted on over-the-counter (OTC) markets—characterized by limited public information and small market capitalizations. They tend to be highly volatile and illiquid, making them speculative, higher-risk investments that are more susceptible to large price swings and market manipulation. These companies had the highest dollar trading volume of any Penny stocks within the last several days.
Erayak Power Solution Group (RAYA)
Erayak Power Solution Group Inc., through its subsidiaries, engages in the research and development, manufacture, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery and smart chargers, and custom-designed products.
Smart Powerr (CREG)
Smart Powerr Corp. engages in the waste energy recycling business in China. The company provides energy saving and recovery facilities for various energy intensive industries; waste energy recycling systems for use in nonferrous metal plants; and clean-technology and energy-efficient solutions to reduce air pollution and energy shortage problems.
Read Our Latest Research Report on CREG
Presidio Property Trust (SQFT)
Presidio Property Trust, Inc. (we, our, us or the Company) is an internally-managed real estate investment trust (REIT), with holdings in office, industrial, retail and model home properties. We were incorporated in the State of California on September 28, 1999, and in August 2010, we reincorporated as a Maryland corporation.
Read Our Latest Research Report on SQFT
Fusemachines (FUSE)
Fusemachines Inc. develops and delivers artificial intelligence (AI) as a service and machine learning software solutions. The company offers Fuse Anna which is an AI assistant for follow ups through daily reminders; and Fuse Prospector which is an artificial intelligence sales platform. Further, the company offers managed outbound services and AI as a service for big data processing, data management, and cloud analytics.
Read Our Latest Research Report on FUSE
Sidus Space (SIDU)
Sidus Space, Inc., a space-as-a-service company, engages in the design, manufacture, launch, and data collection of commercial satellite worldwide. Its space services include satellite/space hardware manufacturing; Low Earth Orbit (LEO) launch and deployment services; and space-based geospatial intel, imagery, and data analytics.
Read Our Latest Research Report on SIDU
XIAO-I (AIXI)
Xiao-I Corporation, through its subsidiary, Shanghai Xiao-i Robot Technology Co., Ltd., provides software services in the People’s Republic of China. It offers conversational AI platform that uses deep learning, data enhancement, active learning technologies for dialog management, context processing mechanisms, and driven by a learning system; knowledge fusion platform which integrates Q&A, documents, multimedia, information forms, business processes, knowledge graphs, and multimodal; intelligence voice platform to enhance intelligent speech solutions, realizing the macro processes of intelligent IVP, intelligent outbound calls, speech analysis, agent assistance, and human-computer interaction; and hyperautomation platform that integrates technologies, such as OCR, NLP, and visualized data mining and analysis that enables users to realize business and process automation.
Read Our Latest Research Report on AIXI
Iovance Biotherapeutics (IOVA)
Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma.
Read Our Latest Research Report on IOVA
See Also
- MarketBeat’s Top Five Stocks to Own in April 2026
- Why Simply Good Foods Stock Just Had Its Worst Day in Years
- Berkshire Bet Constellation Cuts Guidance: Why Shares Rose 8%
- Up Over 200% in 2026, What’s Next for AI Stock Aehr Test Systems?
- WD-40 Company Justifies Sell-Side Support With Q2 Results
- Why PriceSmart’s Discount May Not Last Much Longer
